CD22L-N3
CD22L-N3 (BPC-Sia-LacNAc-N3) is a pharmaceutical intermediate that can be used to synthesize CD22-specific trisaccharide ligands. CD22L-N3 is applicable to the research of B-cell lymphoma.
For research use only. We do not sell to patients.
- CAS No.: 1019642-47-7
- Formula: C40H54N6O19
- Molecular Weight:922.90
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
CD22L-N3 (Compound 8) (0.04-20 μg/mL) mediates concentration-dependent formation of anti-NP IgM-CD22 complexes on BJAB human lymphoma cells, with maximal binding observed at 2.5 μg/mL[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1019642-47-7
-
Molecular Weight 922.90
-
Formula C40H54N6O19
-
SMILES
O(C[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@@H](OCCN=[N+]=[N-])[C@H](NC(C)=O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O)[C@@]3(C(O)=O)O[C@@]([C@@H]([C@@H](CNC(=O)C4=CC=C(C=C4)C5=CC=CC=C5)O)O)([C@H](NC(C)=O)[C@@H](O)C3)[H]
-
Synonyms
BPC-Sia-LacNAc-N3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)